Brief: Arca Biopharma - May Sell Additional Shares Worth Up To $50 Million
April 6 (Reuters) - ARCA Biopharma Inc ABIO.O :
* ARCA BIOPHARMA INC SAYS ON APRIL 6, CO ENTERED INTO
AMENDMENT TO
ITS CAPITAL ON DEMANDTM SALES AGREEMENT WITH JONESTRADING
INSTITUTIONAL SERVICES LLC
* ARCA BIOPHARMA INC SAYS MAY OFFER ADDITIONAL SHARES OF
COMMON
STOCK OFFERING PRICE OF UP TO $50 MILLION - SEC FILING
Source text: (https://bit.ly/2R4FKkY)
Further company coverage: ABIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oruka Therapeutics
See all newsOruka falls after reporting mid-stage data for psoriasis drug
Brief: Oruka Therapeutics Announces Positive Week 28 Data For Orka-001 From The Ongoing Everlast-A Trial Showing Deepening Of Responses Without Additional Dosing
Brief: Oruka Therapeutics Appoints Todd Edwards As Chief Commercial Officer
U.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna Therapeutics
Oruka Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary